Clinical Trial Update: Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update reports that a phase 1/2 trial of CR011-vcMMAE for locally advanced or metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CR011-vcMMAE

Snippet

Sponsor: CuraGen Corporation | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED